All
Plans
spot_img
Runaway Pricing

Former Pharma CEO said the quiet part out loud: “…PBMs are not the bandits here…the pharmaceutical industry charges higher prices in the U.S. than in other countries.”

Share This Post

Novo Nordisk’s outgoing CEO Lars Fruergaard Jørgensen has often argued that the company’s prices are dictated by middlemen – the so-called PBMs. But that explanation is a diversionary tactic, experts now say.

READ FULL ARTICLE

spot_img

Related Posts

CMS.GOV Reports Big Pharma & Medical Device Companies Paid Doctors $2.4 Billion In 2024 For: Travel, Meals, Entertainment, etc.

General Payments defined as: Food, travel, consulting, engagements, entertainment,...

Washington Examiner: Push to rein in reduced drug cost program has Big Pharma’s fingerprints all over it

A powerful group of conservative interest groups and activists...

Bloomberg: Big Pharma quadruples cancer drug pricing since early 2000s

Cancer Drugs Cost More Than Ever. They Often Don’t...

RAND: Big Pharma charges U.S. 3x what other countries pay

Key Findings: Except for unbranded generics, manufacturer gross drug prices...

DailyCaller: CNN Acknowledges RFK’s Drug Ad Ban Could ‘Cripple’ Broadcasting Giants

CNN admitted Wednesday policies to limit pharmaceutical TV advertising...

Big Pharma focused on protecting profits by raising prices in Europe, ignoring dropping prices in U.S.

ARIS, April 15 (Reuters) - Nearly three dozen global...
- Advertisement -spot_img
Previous article
Big Pharma focused on protecting profits by raising prices in Europe, ignoring dropping prices in U.S.
Next article
DailyCaller: CNN Acknowledges RFK’s Drug Ad Ban Could ‘Cripple’ Broadcasting Giants

Unethical:

Profits Over People:

Pharma Reform:

Company:

© Americans For Pharma Reform 2024. All Rights Reserved.

Paid for by Americans for Pharma Reform